The aim of this study was to compare the efficiency of a plant enzyme preparation (Coronase) with animal extracted hyaluronidase to remove cumulus cells before intracytoplasmic sperm injection (ICSI). The first part of the study was performed on mouse oocytes and embryos. Coronase displayed a similar efficiency to that of hyaluronidase for removing cumulus cells and the same percentage of activated oocytes was obtained with both techniques. However, prolonged incubation in Coronase, 120 min, led to a degeneration of oocytes. Incubation of 2-cell mouse embryos for 10 min with Coronase did not affect their subsequent in-vitro development to blastocyst. Coronase was then compared to hyaluronidase in the treatment of human oocytes prior to ICSI. The time required for total denudation was slightly longer using Coronase (98 s ⍨ 25 s versus 84 s ⍨ 24 s respectively for Coronase and hyaluronidase; P Ͻ 0.01). However, the two pronuclear (2PN) fertilization rate (70/103 versus 63/107 respectively for Coronase and hyaluronidase, not significant) and the percentage of embryos with a good morphology (39/74 versus 32/67 respectively for Coronase and hyaluronidase, not significant) were identical with both treatments. In conclusion, Coronase displays an efficiency close to that of hyaluronidase, without any adverse effect on oocytes, and may be preferable for human use.
Introduction
Intracytoplasmic sperm injection (ICSI) is a technique widely used for the treatment of male infertility. When oocytes are collected from ovarian follicles, they are surrounded by cumulus cells and corona radiata, which must be removed before sperm injection. The extracellular matrix in oocytes and cumulus is composed of hyaluronic acid filaments and glycoprotein granules (Dandekar et al., 1992) . Since proteolytic enzymes, such as trypsin, cannot be used to avoid destruction of the zona pellucida, a combination of hyaluronidase treatment and mechanical methods is usually employed to denude the oocytes (Mahadevan and Trounson, 1985) . The use of hyaluron-idase raises two problems, the harmlessness for oocytes and the subsequent development of embryos, and the safety for patients.
Concerning the effect on oocytes, Van de Velde et al. (1997) have shown that high hyaluronidase concentrations (760 IU/ ml) can induce parthenogenetic activation of the oocytes. They have recommended the use of low concentrations of this enzyme (10 IU/ml) and to increase the mechanical step of decoronization. However, an adverse effect of multiple pipettings cannot be excluded since Muechler et al. (1989) have shown that high vacuum pressures used for follicle aspiration could also induce parthenogenetic activation of human oocytes.
Hyaluronidase is found in mammalian spermatozoa, venom of insects and snakes and in salivary glands of leeches (Kreil, 1995) . Purified preparations of the enzyme are commercially available only from bovine or sheep testis and accidental transmission of infection cannot be excluded. Indeed, despite the efficiency of the methods used for the purification and the sterilization of such products, it is impossible completely to avoid risk due to unknown pathogens (Truyen et al., 1995) .
The aim of the present study was to evaluate the efficiency in denuding oocytes and the harmlessness on oocytes and embryos of a preparation containing citric acid and papaïne as well as NaCl and phosphate (Coronase; Bio-Media, Boussens, France).
Materials and methods

Mouse oocytes and embryos
For ovarian stimulation, 5 IU of human menopausal gonadotrophins (Humegon ® ; Organon, Paris, France) were injected intraperitoneally in B6CBA F1 female mice. Ovulation was induced 48 h later by an intraperitoneal injection of 5 IU of human chorionic gonadotrophins (HCG) (Organon). For experiments on oocytes, cumulus-oocyte complexes were recovered from the Fallopian tubes 16 h after HCG injection. For experiments on embryos, female mice were placed with a Swiss male for mating, after HCG injection. Two-cell embryos were then recovered from the Fallopian tubes 40 h after HCG injection.
Experiment 1
To evaluate the effects of Coronase on oocytes, cumulus-oocyte complexes were randomly placed either in Coronase, a ready-to-use salt solution containing citric acid (8 g/l) and papaïne 0.2 g/l (BioMédia, Boussens, France), or in Earle's medium (Sigma, St Louis, MO, USA) containing 80 IU/ml hyaluronidase (Sigma). The time necessary to obtain complete cumulus dissociation in the enzyme solutions, without any pipetting, was recorded. The denuded oocytes were then observed after 10, 20, 30, 45, 60, 90 and 120 min incubation in Coronase or hyaluronidase.
Experiment 2
To evaluate the effect of cumulus removal with Coronase on oocyte activation, oocytes were incubated for 10 min in either Coronase or Earle's medium containing 80 IU/ml hyaluronidase, and then transferred in BM1, a complex medium containing salt, vitamins, amino acids and 1% human serum albumin (Ellios Bio-Media, Paris, France). The time of incubation was about three times higher than that required for denudation, in order to have a safety margin as compared to normal use. The oocytes were then observed after 24 and 48 h incubation.
Experiment 3
To evaluate the effect of Coronase on embryo development, embryos were incubated for 10 min in Coronase and then transferred in BM1 medium containing 15% human serum obtained from a pool of healthy volunteers. The human serum was included to support mouse embryo development. As controls, embryos from the same mouse were incubated in the same conditions except for the pre-incubation in Coronase. The percentage of embryos reaching the blastocyst stage after 4 days was recorded.
Patients
Twenty seven patients undergoing ICSI for failed or very low fertilization rate in a previous in-vitro fertilization (IVF) cycle, or sperm parameters too poor for IVF or epididymal sperm retrieval entered the study.
Ovarian stimulation was performed using a combination of buserelin (Suprefact ® ; Hoechst, Puteaux, France) and recombinant folliclestimulating hormone (Gonal-F 75 ® ; Serono, Paris, France) as previously described (Parinaud et al., 1993) . Four to 17 oocytes (mean: 9.0) were collected by ultrasonically guided puncture.
Oocyte preparation
After collection, oocytes from each patient were pooled in BM1 medium and incubated at 37°C with 5% CO 2 until denudation. Cumulus-oocyte complexes were randomly treated with Coronase or hyaluronidase (80 IU/ml in Earle's medium). Randomization was done on an oocyte basis. In both cases, cumulus-oocyte complexes were each placed in a single 100 µl droplet of the enzyme solution for cumulus removal. When cumulus cells were dissociated and only when the corona radiata remained attached to the zona were they then placed singly in a 100 µl droplet of BM1 and corona was removed using yellow tips (Gilson, Villiers-le-Bel, France) mounted on a P40 pipette (Gilson). In some cases, oocytes were treated one by one and the time required for cumulus removal and for complete denudation was recorded. The oocytes were then rinsed twice in BM1 medium and incubated in BM1 medium until sperm injection.
ICSI procedure
ICSI procedure was identical to the one described by Palermo et al. (1993) . The pipettes were obtained from Cook France (Charenton, France) and polyvinylpyrrolidone from Scandinavian Science (JCD, Gauville, France). After sperm injection, oocytes were placed in BM1 medium and incubated at 37°C with 5% CO 2 . At 16-18h after injection, oocytes were examined for survival and fertilization. The embryo quality was evaluated 40 h after injection according to the score described by Giorgetti et al. (1995) and 1-4 embryos (mean: 3.0) were transferred according to patient's age.
Statistical analysis
Data are means Ϯ SD. Statistical comparisons were performed using Mann-Whitney or χ 2 test as appropriate.
Results
Effects of Coronase on mouse oocytes and embryos
The time for cumulus removal was slightly longer with Coronase than for hyaluronidase (230 s versus 195 s respect-1934 ively for Coronase and hyaluronidase). When studying the effect of prolonged treatments on oocytes, it appeared that until 90 min Coronase had no detectable effect on oocytes but that after a 120 min incubation most of the oocytes degenerated, while no effect was observed with hyaluronidase. To check the effect of treatments on mouse oocyte activation, oocytes were incubated for 10 min in Coronase or hyaluronidase and then transferred in BM1 medium. The rate of parthogenetic activation after a 24 h and a 48 h incubation was identical in both treatments (50 and 70% with Coronase versus 54 and 73% with hyaluronidase; not significant). Similarly, the 10 min pre-treatment of 2-cell embryos with Coronase did not affect their subsequent development into blastocysts (27/50 with Coronase versus 28/52 with hyaluronidase; not significant).
Effects of Coronase in human ICSI
As reported in Table I , the time required for cumulus removal was significantly longer with Coronase than with hyaluronidase, but the maximum length of oocyte incubation in Coronase was 110 s. However, the length for mechanical removal of corona radiata was significantly shorter with Coronase than with hyaluronidase, so that the time necessary to obtain total denudation was very similar with both methods, despite a slight but significant difference in favour of hyaluronidase.
The fate of oocytes after sperm injection was identical with both treatments (Table II) . Indeed, the rate of normal fertilization, i.e. the appearance of two pronuclear (2PN) zygotes, was higher with Coronase (68%) than with hyaluronidase (59%) although the difference did not reach statistical significance. The distribution of embryo scores showed no significant difference between Coronase and hyaluronidase and the percentage of embryos with a good morphology (scores 4 and 3) was identical (53 versus 47% respectively for Coronase and hyaluronidase, not significant).
Discussion
The results of the present study show that Coronase can be used for denudation of oocytes before ICSI. Coronase appeared to be less effective for cumulus removal but more efficient for mechanical denudation than hyaluronidase. This is probably due to the differences in the mechanism of action. Indeed, hyaluronidase is an endo-β-N-acetyl-D-hexosaminidase which hydrolyses the hyaluronic acid filaments (Kreil, 1995) that link together cells surrounding oocytes. Coronase acts in a very different way. The citric acid chelates calcium and thus could act on the binding of hyaluronic acid to the surface of the cells. Indeed, Yannariello-Brown and Wiegel (1992) and Frost et al. (1992) have shown that rat liver sinusoidal endothelial cells and rat hepatocytes possess Ca ϩϩ -dependent and Ca ϩϩ -independent hyaluronic acid binding sites. Coronase may act by chelating Ca ϩϩ and partially detaching filaments from cumulus cells. The other action of Coronase is related to its papaïne content which could degrade the glycoprotein granules present in the extracellular matrix of the cumulus (Dandekar et al., 1992) . In the mouse experiments, it appeared that a 2 h incubation in Coronase induced degeneration of oocytes, which is not the case with hyaluronidase. However, this adverse effect appeared only for very long incubation times since the mean time required for cumulus removal is only 1 min. Moreover, a 10 min incubation in Coronase did not increase the rate of parthogenetic activation of oocytes and did not affect the ability of embryos to reach the blastocyst stage. These findings are in good agreement with the results of the ICSI trial in which no difference either in the oocyte survival rate after sperm injection, or in the fertilization rate or in the embryo quality was found. Therefore, for the conditions used in the present study for oocyte denudation before ICSI, Coronase has no apparent adverse effects on the oocyte. However, careful washing of the oocytes is required after denudation with Coronase.
The absence of any human or animal compound in Coronase may avoid contamination by animal pathogens.
